Coya Therapeutics (COYA) FCF Margin (2023 - 2025)
Coya Therapeutics (COYA) has disclosed FCF Margin for 3 consecutive years, with 25.43% as the latest value for Q4 2025.
- Quarterly FCF Margin rose 12342575.0% to 25.43% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 135.16% through Dec 2025, up 15434.0% year-over-year, with the annual reading at 135.16% for FY2025, 15434.0% up from the prior year.
- FCF Margin hit 25.43% in Q4 2025 for Coya Therapeutics, up from 31.72% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 1691.82% in Q1 2024 to a low of 123451.18% in Q4 2024.
- Historically, FCF Margin has averaged 15826.55% across 3 years, with a median of 85.28% in 2024.
- Biggest five-year swings in FCF Margin: crashed -12341384bps in 2024 and later soared 12342575bps in 2025.
- Year by year, FCF Margin stood at 37.34% in 2023, then crashed by -330535bps to 123451.18% in 2024, then soared by 100bps to 25.43% in 2025.
- Business Quant data shows FCF Margin for COYA at 25.43% in Q4 2025, 31.72% in Q3 2025, and 3528.56% in Q2 2025.